Yali An
About
Yali An is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Yali An has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yali An's work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Metabolism, Diabetes, and Cancer (18 papers) and Diabetes Treatment and Management (10 papers). Yali An is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Metabolism, Diabetes, and Cancer (18 papers) and Diabetes Treatment and Management (10 papers). Yali An collaborates with scholars based in China, United States and Switzerland. Yali An's co-authors include Qiuhong Gong, Jinping Wang, Guangwei Li, Yinghua Hu, Ying Shuai, Edward W. Gregg, Peter H. Bennett, Wenying Yang, Ping Zhang and Gojka Roglić and has published in prestigious journals such as The Lancet, Diabetes Care and Diabetes.
In The Last Decade
Yali An
30 papers receiving 1.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yali An China | 11 | 1.2k | 469 | 346 | 340 | 311 | 33 | 1.9k | ||
| Ying Shuai China | 9 | 1.2k 1.0× | 442 0.9× | 331 1.0× | 311 0.9× | 278 0.9× | 19 | 1.8k | ||
| Qiuhong Gong China | 11 | 1.4k 1.1× | 520 1.1× | 383 1.1× | 387 1.1× | 342 1.1× | 43 | 2.1k | ||
| Katri Hemiö Finland | 10 | 833 0.7× | 456 1.0× | 396 1.1× | 176 0.5× | 191 0.6× | 16 | 1.6k | ||
| Merja Paturi Finland | 6 | 795 0.6× | 432 0.9× | 408 1.2× | 169 0.5× | 171 0.5× | 10 | 1.4k | ||
| Jiang Yayun China | 4 | 837 0.7× | 318 0.7× | 239 0.7× | 196 0.6× | 186 0.6× | 6 | 1.2k | ||
| Maria G. Montez United States | 17 | 908 0.7× | 260 0.6× | 242 0.7× | 225 0.7× | 190 0.6× | 24 | 1.6k | ||
| Michael Stern United States | 7 | 1.3k 1.1× | 453 1.0× | 344 1.0× | 323 0.9× | 563 1.8× | 12 | 2.1k | ||
| Christine Massien France | 13 | 563 0.5× | 459 1.0× | 434 1.3× | 231 0.7× | 372 1.2× | 23 | 1.6k | ||
| Joanna Mitri United States | 20 | 887 0.7× | 1.2k 2.5× | 693 2.0× | 455 1.3× | 324 1.0× | 52 | 3.2k |
Countries citing papers authored by Yali An
Since
Specialization
Citations
This map shows the geographic impact of Yali An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali An more than expected).
Fields of papers citing papers by Yali An
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yali An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali An. The network helps show where Yali An may publish in the future.
Co-authorship network of co-authors of Yali An
This figure shows the co-authorship network connecting the top 25 collaborators of Yali An. A scholar is included among the top collaborators of Yali An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali An. Yali An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chen, Yanyan, Jinping Wang, Xinxin Feng, et al.. (2025). Stroke Incidence Evolution in People With Newly Diagnosed Diabetes and Impaired Glucose Tolerance: A 34-Year Follow-up of the Da Qing Diabetes Study. Diabetes Care. 48(10). 1721–1727.
2.
He, Siyao, Xin Qian, Jinping Wang, et al.. (2025). Younger-onset type 2 diabetes associated with increased long-term cancer risk in Chinese adults: A 30-year follow-up of the Da Qing Diabetes Study. PubMed. 3(1). 24–24.
3.
Qian, Xin, Hong‐Mei Jia, Jinping Wang, et al.. (2024). Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing Diabetes Study. Cardiovascular Diabetology. 23(1). 37–37.
4.
Chen, Fei, Jinping Wang, Siyao He, et al.. (2024). Influence of impaired glucose tolerance and type 2 diabetes on the multimorbidity cluster of cardiovascular disease and cancer: a post hoc analysis of the Da Qing Diabetes Prevention Outcome Study. BMC Medicine. 22(1). 534–534.
5.
Yu, Liping, Jinping Wang, Qiuhong Gong, et al.. (2024). Influence of a diet and/or exercise intervention on long‐term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study. Diabetes Obesity and Metabolism. 26(4). 1188–1196.
6.
He, Siyao, Jinping Wang, Yali An, et al.. (2024). Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study. Diabetes Obesity and Metabolism. 26(6). 2329–2338.
7.
Qian, Xin, Jinping Wang, Qiuhong Gong, et al.. (2024). Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study. PLoS Medicine. 21(7). e1004419–e1004419.
8.
Chen, Fei, Jinping Wang, Xiaoping Chen, et al.. (2023). Development of models to predict 10-30-year cardiovascular disease risk using the Da Qing IGT and diabetes study. Diabetology & Metabolic Syndrome. 15(1). 62–62.
9.
Chen, Yanyan, Hong‐Mei Jia, Xin Qian, et al.. (2022). Circulating Palmitoyl Sphingomyelin Is Associated With Cardiovascular Disease in Individuals With Type 2 Diabetes: Findings From the China Da Qing Diabetes Study. Diabetes Care. 45(3). 666–673.
10.
He, Siyao, Jinping Wang, Xiaoxia Shen, et al.. (2022). Cancer and its predictors in Chinese adults with newly diagnosed diabetes and impaired glucose tolerance (IGT): a 30-year follow-up of the Da Qing IGT and Diabetes Study. British Journal of Cancer. 127(1). 102–108.
11.
Wang, Haixu, Siyao He, Jinping Wang, et al.. (2022). Hyperinsulinemia and plasma glucose level independently associated with all-cause and cardiovascular mortality in Chinese people without diabetes—A post-hoc analysis of the 30-year follow-up of Da Qing diabetes and IGT study. Diabetes Research and Clinical Practice. 195. 110199–110199.
12.
He, Siyao, Jinping Wang, Xiaoxing Zhang, et al.. (2022). Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults — A 30-year follow-up of the Da Qing diabetes study. Diabetes Research and Clinical Practice. 191. 110048–110048.
13.
Chen, Yanyan, Zhang Ping, Jinping Wang, et al.. (2021). Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. Diabetologia. 64(6). 1279–1287.
14.
Zhao, Yanping, Jinli Cui, Liping Fang, et al.. (2021). Roxarsone transformation and its impacts on soil enzyme activity in paddy soils: A new insight into water flooding effects. Environmental Research. 202. 111636–111636.
15.
Toupin‐April, Karine, Yali An, Siyao He, et al.. (2020). Patient decisional needs when considering treatment intensification for type 2 diabetes: A qualitative study in China. Diabetes Research and Clinical Practice. 170. 108471–108471.
16.
Wang, Jinping, Yali An, Qiuhong Gong, et al.. (2019). Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study. Endocrine. 65(1). 46–52.
17.
Chen, Yanyan, Jinping Wang, Yali An, et al.. (2015). [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].. PubMed. 54(1). 13–7.
18.
Li, Guangwei, Ping Zhang, Jinping Wang, et al.. (2014). Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. The Lancet Diabetes & Endocrinology. 2(6). 474–480.
19.
Zhang, Bo, Jiang Yayun, Ying Shuai, et al.. (2010). Improving glucose intolerance linked with the reduction of cardiovascular disease events and mortality in a Da Qing population with pre-diabetes-a 20 year follow-up study. Zhonghua neifenmi daixie zazhi. 26(1). 6–9.
20.
Li, Guangwei, Ping Zhang, Jinping Wang, et al.. (2008). The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet. 371(9626). 1783–1789.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ying Shuai Breakdown of academic impact, for papers by Qiuhong Gong Breakdown of academic impact, for papers by Katri Hemiö Breakdown of academic impact, for papers by Merja Paturi Breakdown of academic impact, for papers by Jiang Yayun Breakdown of academic impact, for papers by Maria G. Montez Breakdown of academic impact, for papers by Michael Stern Breakdown of academic impact, for papers by Christine Massien Breakdown of academic impact, for papers by Joanna Mitri